Shopping Cart
Remove All
Your shopping cart is currently empty
Ru-TRZ2 is an effective ruthenium-based chemotherapeutic agent that can induce apoptosis and necroptosis. It also exhibits antitumor activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Ru-TRZ2 is an effective ruthenium-based chemotherapeutic agent that can induce apoptosis and necroptosis. It also exhibits antitumor activity. |
| In vitro | Ru-TRZ2 (72 h) induces necroptosis, with IC50 values of 0.45 µM and 0.24 µM for HCT116 and HT29 cells, respectively. It also triggers mitochondrial depolarization and apoptosis in HT29 cells. |
| In vivo | Ru-TRZ2, administered intravenously at a dosage of 5 mg/kg every two days for a total of 10 injections, demonstrates antitumor activity in HT29 xenograft mice. |
| Formula | C45H43F6N4O7P2RuS2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.